Anti-metastasis therapy via nanoparticle mediated drug delivery [ 2017 - 2020 ]

Research Grant

Researchers: Prof Robin Anderson (Principal investigator) ,  Dr Angus Johnston ,  Prof Christopher Porter

Brief description Most cancer deaths are caused by tumours that have spread to other vital organs, a process called metastasis. The common treatment for metastatic disease is chemotherapy, but the amount given is limited by toxicity to the patient. In this project, we are developing a way of delivering the therapies only to tumour cells, thereby sparing normal tissues. We are using nanoparticles that have a molecule on their surface that directs the therapy directly to tumour cells.

Funding Amount $AUD 856,397.88

Funding Scheme Project Grants

Notes Standard Project Grant